Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
4.460
-0.030 (-0.67%)
At close: Dec 12, 2025, 4:00 PM EST
4.610
+0.150 (3.36%)
After-hours: Dec 12, 2025, 7:58 PM EST
Inventiva Revenue
Inventiva had revenue of 2.81M EUR in the half year ending June 30, 2025, with 105.19% growth. This brings the company's revenue in the last twelve months to 12.07M, down -11.15% year-over-year. In the year 2024, Inventiva had annual revenue of 14.72M, down -36.43%.
Revenue (ttm)
12.07M EUR
Revenue Growth
-11.15%
P/S Ratio
42.31
Revenue / Employee
102,322 EUR
Employees
118
Market Cap
843.15M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.72M | -8.44M | -36.43% |
| Dec 31, 2023 | 23.16M | 4.35M | 23.12% |
| Dec 31, 2022 | 18.81M | 10.31M | 121.32% |
| Dec 31, 2021 | 8.50M | 3.24M | 61.52% |
| Dec 31, 2020 | 5.26M | -6.03M | -53.39% |
| Dec 31, 2019 | 11.29M | 3.91M | 53.02% |
| Dec 31, 2018 | 7.38M | -2.58M | -25.90% |
| Dec 31, 2017 | 9.96M | 512.36K | 5.42% |
| Dec 31, 2016 | 9.45M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
IVA News
- 21 days ago - Inventiva reports 2025 Third Quarter Financial Information¹ - GlobeNewsWire
- 25 days ago - Inventiva announces full exercise of Underwriters' Option, bringing proceeds of Offering to approximately $172.5M - GlobeNewsWire
- 4 weeks ago - Inventiva announces trading resumption of its ordinary shares on Euronext Paris - GlobeNewsWire
- 4 weeks ago - Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary Shares - GlobeNewsWire
- 4 weeks ago - Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris - GlobeNewsWire
- 4 weeks ago - Inventiva announces launch of public offering - GlobeNewsWire
- 2 months ago - Inventiva Announces the Implementation of a New ATM Program - GlobeNewsWire
- 2 months ago - Inventiva S.A. (IVA) Analyst/Investor Day Transcript - Seeking Alpha